MedTrace Logo

Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance

NCT02171078 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34359

Last updated 2022-12-27

No results posted yet for this study

Summary

Nearly three million living women have survived breast cancer. Physicians rely on clinical practice guidelines to make decisions on follow-up care. Among other things, the goal is to monitor for recurrence or side effects of treatment among survivors. It is unclear whether these guidelines represent the best approach for any given patient as they do not account for differences in disease or patient preferences and may not consider recent advances in imaging and treatment options. We seek to develop a new approach to surveillance following breast cancer treatment which will be more patient-centered and effective than the existing one-size-fits-all approach and will consider individual risk factors.

Conditions

  • Breast Neoplasms

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • American College of Surgeons

    collaborator OTHER

  • Alliance for Clinical Trials in Oncology

    collaborator OTHER

  • Harvard University

    collaborator OTHER

  • Dana-Farber Cancer Institute

    collaborator OTHER

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Caprice C Greenberg, MD MPH · University of Wisconsin, Madison

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02171078 on ClinicalTrials.gov